1473
PŘEHLEDOVÉ479422701004388130181216258306358404446
ČLÁNKY525622701003973122176223272
Léčba38513370100316698136171
nemocnění403833701003773133172202240276314329
asociovaného438333701003463102133148187223258296331369408
s4807337010028
imunoglobulinem485133701001574112150189227243282320358373388426461521
IgG4538833701001755100139
|5584227010018
E215617227010066104134
/35578043010757
Vnitř36338043010771118137165192
Lék.3844804301074184122140
2022;68(6):E15-E224004804301074487128172187232277301343365379422461499526570615658
/46828043010757
VNITŘNÍ47598043010791152173217266326347
LÉKAŘSTVÍ5126804301074185131189236281326378400
www.casopisvnitrnilekarstvi.cz42580430107651332012142542953293774274464795215705896176436927117307748128548809159449871007102310631101
13.425553085366883
Hart523554083427495119
PA,658554083326983
Topazian7565540833164104136166181213251
MD,10225540835298108
Witzig1146554083547093123139177
TE13385540833064
et14185540833153
al.1486554083304558
Treatment1559554083304781112134192227264286
of18605540833554
relapsing192955408318526899138165180217256
autoimmune2200554083306789126141199256293331366
pancreatitis25815540833669107139160194225247262284300325
with425654083506587124
immunomodulators5646540831269126162200237294332371408423454475511532559
and11386540832966104
rituximab:125765408318335592123138195226265277
the1548654083195791
Mayo16546540835183113150
Clinic1819654083365166103117149
experience.19836540833061100135156171205242273306318
Gut.23166540834178100113
2013;62(11):1607–2444654083316495125136171203220251278292304333363398430462
1615.425754083346596126138
14.425853085377187
Yoshikawa5298540834177104144159191225278312
M,8578540836175
Muro94985408361100122161
Y,11268540834150
Ogawa‑Momohar,11928540835495129181215238296336396436476509531542
M.A.17508540836176121137
case1903854083377199135
with2054854083587497137
overlapping22078540834477113135151185225266283322362
features2585854083256093116156178213241
of28428540834464
IgG4-related4259540831557104142166190226244278301337379
autoimmune8219540834585109149166226287326367404
pancreatitis,12429540835287128162185221255278295319336364379
Sjögren’s16379540834763103145168204244258285
syndrome19399540833974115156179219280317
and22739540834586127
anti‑aminoacyl­24179540834586109126150184245261301342377411447464488
‑tRNA4251054083214683132175
synthetase61710540833973114137178215239273302339
syndrome.97310540833873114155178217278315329
Mod1319105408368108150
Rheumatol148610540834889126166226261284323340
Case184310540835388116154
Rep.201310540834986127141
2021217110540834783118151
Jan;5(1):82-86.233910540833771111124162181214230243280316338376413428
doi:278410540835191108122
10.1080/24725625.2020.1816675.,4251154083346678109140176211236271302334369404438471506518554588621655668699730762793828861894906919
15.4251253085366883
Wang52312540835788126165
L,70312540833145
Zhang76312540833775107145184
P,96212540833439
Wang101612540835788126165
M1196125408354
et126512540833356
al.13361254083314659
Failure1411125408331607691128149183
of161012540833655
remission168112540832054112127153179194232271
induction19671254083145291128160184200238276
by225812540833869
glucocorticoids23431254083375290122159192228250275290322359374413439
alone2798125408331468442513540833873
or51413540834264
in59413540832058
combination66813540833674132172188226259281296335374
with10571354083567295134
immunosuppressive120613540832078137175213252279317356396418452480507522555589
agents181113540833776112150172200
in202713540832058
IgG4-related210013540832060105141165187222237270292326366
disease:24821354083435985120153180215228
a2725135408337
prospective27781354083446610442514540832665101133157173205240
study6801454083254886125157
of85214540833756
2159231454083346595
patients.10331454083387193108143181202230244
Arthritis12921454083406186124145161183199225
Res15321454083346996
Ther2018;164414540833170105127158192224255267
20:65.19271454083336780115149161
doi:10.1186/s13075-018-1567221031454083387691103133164177208235267302327351381411446478511533570602633656687717751784425155408334
pmid:2963610947415540833997113151164199233268302337367398433
16.4251653085366985
Omar525165408352111143164
D,70516540835061
Chen78116540834583118156
Y,95316540834048
Cong101716540834482120159
Y,119116540834149
Dong125516540835189128167
L.143716540833750
Glucocorticoids150316540834864102134171204241262287302334371387425452
and197016540833775114
steroid20991654083325588110147162201
sparing231616540833170103124140177217
medications254816540836297137152184217239254292331357
monotherapies42517540835796134172194232267289322361376411438
or87817540834062
in95517540831755
combination102517540833471129168184222254276291329367
for14081754083215880
IgG4-RD:150317540831756101137160197244257
a1775175408334
systematic18251754083286188111145202235257272304
review21441754083235790105140191
and235117540833472111
network24771754083407597150188210240
meta­273317540836095117150172
‑nalysis[Oxford].4251854083216092107139166181207226272303325362384422442454
Rheumatology89418540833574109146204237258295311349389421
(Oxford)2019;kez380.13301854083196597118156177215235268302334364377407441471507541577589
doi:10.1093/rheumatology/kez38019351854083387691103133165177208239275307332351390425462520553574611627665705737760791826855891926961
17.4251953085366876
Bektaş51719540834075105129162189
M,72119540835872
Ağargün80819540834583115136174212250
BF,10731954083407379
Torun11671954083367092130168
ES135119540833670
et143619540833860
al.15121954083355164
Pure15911954083397697131
Red173819540833974113
Cell18671954083437793108
Aplasia199019540834584100132159174206
in221119540831956
IgG4-Related228319540831858102138161198233249281303337376
Disease:26741954083506591126158185220232
Successful42520540833371104135169197224244283299
Treatment7402054083385690123145204239278300
With105620540836380103141
Cyclosporine.121320540834674106122161188227267289305343379391
J1620205408330
Clin16662054083456176115
Rheumatol.179620540834180116154213246268306322335
2020214720540834074108142
Dec230520540835187121
14.24412054083407284
doi:25412054083448399111
10.1097/26682054083407284116148184217237
RHU.0000000000001666.42521540833581125136171207243280316352388424460496532569600632667703716
Epub115621540833372110149
ahead132121540833169104136175
of151221540833756
print.15842154083386075113135148
18.4252253085366985
Yunyun52522540833469108138177215
F,75522540833137
Yu80722540833470
C,89222540833952
Panpan95922540833466104143176214
Z1188225408337
et124022540833355
al.13102254083314659
Efficacy1385225408331496784117149182215
of161522540833656
cyclophosphamide16862254083306495110149188227265292331369401459474513548
treatment22492254083214276108130188223261283
for25472254083175577
immunoglobulin2639225408313711291672052434252354083385391131169184199237
G4-related67723540834277100122156172204225259299
disease9912354083365177112143170205
with12112354083486486124
addition135023540833069108123145161198237
of160223540833554
glucocorticoids.16712354083365189121158190227249273288320357373411438451
Sci21372354083306378
Rep.223023540833368107119
2017;7(1):6195-6198.23652354083326697127136169185217231243279309339373395432462492527541
19.4252453085366982
Yunyun52224540833469107138176214
F,75224540833137
Yu80424540833469
P,88824540833438
Panpan94224540833465103143176214
Z1171245408336
et122324540833254
al.12932454083304558
Efficacy1367245408331496784116149182215
and159724540833169108
safety17202454083255877111134167
of190324540833655
low197324540831452103
dose209124540833775102137
Mycophenolate224324540835385116153193231266304342358391412446
mofetil270424540835695114148171186201
treatment4252554083224377109131189224262284
for7242554083215980
immunoglobulin82025540831775133171209247286302340379418433448486
G4-related132125540834783106128162177210231265305
disease:16412554083415682117149176211223
a1880255408334
randomized19302554083235694133172230245274308348
clinical22932554083345064102117149182198
trial.2506255408325466294109122
Rheumatology(Oxford).2643255408339771121502082404252654083225975113152184204250281303340362400420431
2019;58(1):52-60.87126540833468100130143178212231263277289324358378415451463
doi:13502654083387691103
10.1093/rheumatology/key227.14692654083346578109140175208232252290325363421453475512528566606638661692726758789824857863
20.4252753085367287
Drobysheva52727540834365102141172199237272304337
A,87927540833852
Fuller947275408330668196131152
J,111427540832234
Pfeifer11632754083335387102121156177
CM,135527540833792106
Rakheja14762754083336696135170185217
D.170827540834354
Orbital177727540834566106121144176191
Granulomatosis19842754083416295133171186224282314336372399414440
With24392754083557193131
Polyangiitis25862754083326985116149187226241256278293319
Mimicking42528540835468125139170200215252290
IgG4-Related7302854083125093128151187221236267288321359
Disease11042854083425782116147173207
in132628540831148
a1389285408329
12-Year‑Old14322854083316080112142173193212261276314
Male.17612854083518397131143
Int19192854083114869
J2003285408321
Surg20392854083296586123
Pathol.21762854083326384122159174186
201823772854083316495125
Aug;26(5):453458.25172854083387411212315719020824125827030333536742529540833467101115
doi:5552954083387692104
10.1177/1066896917754252.6742954083346678109137166201221254285321356392426462496528557592624659692727760773
21.4253053085366981
Luo52130540832965103
X,63930540833548
Peng70230540833366103142
Y,85930540833240
Zhang91430540833572104141180
P1109305408332
et115630540833153
al.12243054083294457
Comparison129630540833773131170202223238264302340
of165030540833554
the17193054083195691
Effects18253054083304867101133157184
of202430540833553
yclophosphamide20923054083296075112151189227253292330361418433472506
and261330540832966105
Mycophenolate27333054083518211315042531540833977112150189204237258292
Mofetil73231540835492111146168183198
Treatment9463154083314882114136194229267289
Against125031540833978110125163189213
Immunoglobulin147831540831371129167205243282298336375414429444482
G4-Related197531540834278101138173189221243277316
Disease:23063154083446086121153179214227
A2548315408340
Retrospective260331540833469911131501772162512844253254083223769104
Cohort54432540833976115153175200
Study.7593254083325391130162172
Front9463254083325289128149
Med111032540835489129
(Lausanne).12543254083185083121147180218256291309320
2020158932540833468101135
Jul17393254083246277
7;7:253.1831325408334447787122157190202
doi:20493254083377591103
10.3389/fmed.2020.00253.21673254083346578113146181215238258317352391404440474507541554589625658693726738
22.4253353085367288
Yamamoto52833540833463121153211249271308
M.85233540835266
B933335408334
cell982335408329637994
targeted10913354083205274112147169203242
therapy13493354083195792114147186217
for15813354083175476
immunoglobulin167233540831371129166204242282297335375413429443481
G4-related216933540834177100122156172204226260299
disease.24833354083375278113145171206218
Immunol2717335408313701281664253454083387692
Med.53234540835590129142
202169034540833468101132
Feb83734540833367106
14:1-7.9583454083356678108126158164
doi:11373454083387692104
10.1080/25785826.2021.1886630.12563454083346678109141176211236271306339372406441474508521557591624655665696727762797833867901914
23.4253553085367287
Khosroshahi52735540833372110137158195222259292330345
A,88735540833853
Bloch9553554083334886119157
DB,11273554083437992
Deshpande123435540834378105143182215253292327
V1576355408333
et162435540833254
al.16933554083304558
JH.17663554083226780
Rituximab18613554083334971109140156213246285
therapy21613554083195893114147186217
leads23933554083134779118144
to255335540831956
rapid26243554083185190106145
decline2784355408336701034253654083153068103
of54336540833959
serum6173654083286384123180
IgG481336540831756101136
levels9653654083175184118134160
and114036540833472111
prompt126636540834162100158197219
clinical15013654083334863101116148181196
improvement171336540831674113135172204238296331369391
in211936540831755
IgG4-related218936540831756101137160182216231264285319359
systemic25633654083286188111145202218250
disease.2828365408340554253754083266193120155167
Arthritis6073754083416287125146162184200226
Rheum84837540833574109147204
2010;62(6):1755-1762.106837540833468100131144180213231264282294324353386418440471500532566578
24.4253853085367186
Khosroshahi52638540833372110137158195222259292330345
A,88638540833953
Carruthers9543854083387092113151174212247268295
MN,126538540835297110
Deshpande139038540834379105143182215253292327
V1732385408333
et178138540833154
al.18503854083294558
Rituximab19233854083334871109140155213245284
for22233854083165375
the23133854083205893
treatment24213854083194175106128186221259281
of271738540833554
IgG4-related278638540831352974253954083345677111126157178211250
disease:6903954083355075109140166200212
lessons917395408312467298136173199
from11313954083153773131
10127639540833162
consecutive135339540832864102128162194231253267299333
patients.17003954083366889104138175196223236
Medicine195139540835186124139170185222256
(Baltimore).2222395408316518398119134191228249283299310
2012;91(1):5766.254739540833164951241361712022172482622733083404254054083347083
25.4254153085367287
Carruthers5274154083397293115153176214249270297
MN,84041540835398111
Topazian96741540833165105138167183215253
MD,123541540835499110
Khosroshahi136141540833373111138159196223260293331346
A1722415408340
et177741540833356
al.18484154083314659
Rituximab19224154083345072110142157215247286
for22244154083175576
IgG4-related23164154083135297133156178212228260282315355
disease:26864154083375278113145172207219
a425425408332
prospective,4724254083396098124163199231256271303338350
open‑label83742540833777112150173189221261296312
trial.1164425408322435991106119
Ann129842540834180118
Rheum,143142540833574109146204217
DiS.16634254083466194107
2015;74(6):1171–1177.178542540833468100130141174204224257275287317344374406439470498527562568
26.4254353085367187
Ebbo52743540833372112151
M,69343540835568
Grados7764354083446699138176203
A,99443540834155
Samson106543540833265123150188226
M,130743540835468
et139043540833457
al.14624354083324760
Long‑term153843540833168107146168191224246304
efficacy1857435408335537189121154186219
and209243540833270109
safety22164354083265978113135169
of240043540833857
rituximab2472435408321375997128144202234273
in276143540831452
IgG4-related28294354083155442544540834479102124159174206228262301
disease:7424454083425884119151177212225
Data98244540835082104137
from11344454083234582141
a1290445408336
French13424454083375690128161199
nationwide15564454083427496111149188238254293328
study18994454083315492131163
of207744540834261
thirty‑three21544454083266479100125159180203241262296332
patients.25014454083437698113148186208235249
PLoS276544540834071108140
One42545540834785120
2017;12(9):e0183844.5604554083316596125135165194211244261273307342374405438472508545557
Published113245540833369108124139164202236276
online14234554083347287102140174
201716124554083326697126
Sep175345540833065104
15.18724554083316173
doi:19604554083357388100
10.1371/journal.pone.018384420754554083326375105135167199220236274312333371403418431470509547581593628660690724758794830
27.4254653085367180
Backhus52046540833871103133172210236
J,77146540832639
Neumann82546540834682119177209247285
C,112646540834255
Perkhofer11964654083377092122162200219254275
L1486465408334
et153546540833658
al.16084654083345062
A1686465408343
Follow‑Up17444654083347288103141192214260299
Study20584654083355694133165
of223846540833958
a2312465408334
European23614654083347192129169205236274
IgG4-Related2651465408316561001361591962314254754083154769103143
Disease5844754083506692128160187222
Cohort82147540834683122160182207
Treated10434754083385690122144178218
with12764754083567295133
Rituximab.14254754083405679117149164222255295307
J1748475408329
Clin17934754083456075114
Med.192247540836095135148
2021;10(6):1329.208647540833974107139147177209229262281293323353386420431
doi:25334754083438297109
10.3390/26584754083397184120153186222247
jcm10061329.42548540831547105135166202238268298331365376
28.4254953085367288
Gu52849540834684
WJ,6274954083608193
Zhang73549540834078110148187
Q,93749540834963
Zhu101549540834077115
J1145495408326
et.11874954083355871
al.12734954083344962
Rituximab13514954083375275113144160217250289
was165549540835385112
used178249540833966101140
to193749540832461
treat20134954083244579111133
recurrent21614954083225789127148170204242264
IgG4-related244049540831756100136159181215231263285319358
hypophysitis28144954083396942550540833977117156186213228251266292
with7325054083536891129
ophthalmopathy87650540834079118139177210225283321361394415454484
as137550540833461
the14515054083246297
initial1563505408317557092107139155
presentation:17335054083416296123158196218251272288326364376
A2125505408343
case21835054083336692127
report23265054083225696135156181
and252250540833472111
literature2648505408317325488109142164202223257
review.4255154083215587103137189199
Medicine64051540835489129144176191229264
(Baltimore)9195154083195588103125141198237258292310
2017;96(24):e6934.124451540833468100130139175210229263295312324359394428461496509
29.4255253085367285
Shao52552540833068100138
SAN,67852540833171116129
Chia‑der8225254083387590122145185220241
LIN,10785254083294489102
Sheng‑ta119552540833068103141180202225257
TSAI146752540833164105120
et160252540833254
al.16715254083304558
Immunoglobulin174452540831270128165203241280296334373411426441479
G4-Related223852540834177100137172187219241275314
Disease25675254083435985120151178213
Presented279552540833253874255354083266098119152191
as63153540832955
Recurrent7015354083336799136157178212249271
Otitis9875354083446782104119144
Media114653540835286125140171
and133253540832967105
Mixed14525354083526797131170
Hearing163753540834175107127143180218
Loss18705354083296692118
Treated20035354083304780111133166205
With22235354083547092130
cyclophosphamide23685354083286192107144183221259285324362393450465503538
and42554540833270109
Rituximab:5495454083365174111143158216248288300
Arch8645454083416394132
Rheumatol.101154540833574109146204237258295311324
2019;34135054540833569100131143178214
(2):233–237.1579545408319537182118152185222253288320326
30.4255553085367287
Wu52855540835894
A,63855540834155
Andrew70855540834179118139173225
NH,94855540834589102
Tsirbas1065555408333557091130163190
A1270555408341
et132655540833457
al.13985554083324760
Rituximab14735554083365174112143158216248288
for17765554083185678
the18695554083216095
treatment19795554083214377109131189224262283
of227855540833756
IgG4-related23505554083145398134157179213229261283316356
orbital27215554083375999114137169185
disease:4255654083385379114146173208220
experience66156540833465105140161177212250282316
from9925654083184078136
five11435654083173467101
cases.12595654083316491126153166
Eye14415654083326398
(Lond)15545654083185087126165184
2015;29175456540833468100130141176210
(1):122-128.1979565408319506577106136171191222252286299
31.4255753085366981
Aouidad52257540834380118134172205244
I,78157540831629
Schneider82557540833467105143178193232267288
P,112857540833741
Zmuda118557540833997134173206
M1406575408356
et147757540833658
al.15505754083344962
IgG4-Related162757540831756100136159196231247279301335374
Disease20175754083466288123155181216
With22495754083597597135
Orbital240057540834870110125148181196
Pseudotumors2611575408337639813617521323527342558540835796117145
Treated5855854083375589121142176216
With81658540836279101139
Rituximab9705854083415679117148164221254293
Combined127858540834582140180195233268308
With160158540836279101139
Palpebral17565854083407287126161201222255271
Surgery.20425854083377596134169190224234
JAMA229258540832969124166
Dermatol247458540835085107165197219256272
2017;276158540833974105135144
153(3):355-356.4255954083346497115149166178213246279301333366400414
32.4256053085367186
Berta5276054083377293118151
AI,6936054083425770
Agaimy77860540834281113128186216
A,101060540834256
Braun10816054083375891129167
JM,12636054083258094
et137260540833557
al.14456054083324861
Bilateral1521605408336526799121155176209224
Orbital176160540834869109125147180195
IgG4-Related19726054083155599135158195230246278300334373
Disease23606054083476288123155182217
with25926054083526790128
Systemic2735605408334649111414842561540835772104
and54561540833371110
Corneal67061540834279100139174206221
Involvement9066154083175586123139172206264299337359
Showing128061540833472110161177215254
an154961540833371
Excellent16356154083346798132148163197236257
Response19076154083377299138177215242277
to219961540832360
Steroid22746154083345589110147163202
and249161540833371110
Rituximab26176154083365274112144159217249288
Therapy:42562540833372107128161200231245
Report68562540833671110149170195
of89562540833857
a967625408332
Case101462540834073100135
with11646254083506688127
11130662540833462
Years13836254083356698119147
Follow‑Up.15456254083327086101139190212258297309
Orbit186962540834769109124147
2015;34(5):203162540833468100130141176211231264283295
299-301.234162540833468104127160194226235
33.4256353085357084
Caso5246354083376994132
F,67163540832934
Fiocco7206354083294481112142178
U,91363540834151
Costa9796354083367298121153
L1147635408328
et119063540833052
al.12576354083284355
Successful13276354083296697127160186212231269284
use16256354083346094
of173463540833452
rituximab1801635408318335592122137194225263
in207963540831249
a2142635408329
young218663540832864101138177
patient23776354083366889104137174195
with25876354083476284121
immunoglobulin27236354083126812516142564540833775114128166205242257272309
G4-related7496454083407598119153168200221254293
disease10576454083354975109140166201
and127364540832866104
refractory1392645408318517092124155179215236270
scleritis.16776454083235469104124139161176202215
Joint19076454083215974111132
Bone205464540833270108142
Spine.22116454083296883120154166
2014;23926454083316496126137
81(2):190-192.25446454083326377111128140169198233257287317349361
34.4256553085367388
Chen52865540833875110148
TS,6916554083316477
Figueira7836554083304583121156171192225
E,102365540833043
Lau108165540832962100
OC119665540834586
et129765540833254
al.13666554083294557
Successful14396554083306799130163190216236275290
„medical“174465540831877112151166198231246268
orbital20276554083355696111134166182
decompression222465540833570103139198237258292319345360398436
with26756554083486486124
adjunctive2814655408330694256654083155290123147162195229
rituximab669665408319345795126141199232271
for9556654083165475
severe10466654083245991125146180
visual12426654083294571108141156
loss14136654083135178104
in153366540831250
IgG4-related15986654083135297132155177212227259281315354
orbital19686654083355696111134167182
inflammatory2165665408313516885117175233265287324346380
disease25606654083365177112144170205
with27816654083486486124
orbital4256754083375998114136169185
myositis.62567540835788126152167190205231245
Ophthal88567540834787125147185217233
Plast11336754083355082109132
Reconstr128067540833570103140178205228249
Surg.15456754083327091129142
2014;30(5):e122-125.170267540833468100131143178213232266284296331360390425445476506541553
35.4256853085367186
Savino52668540833871103119157196
G,73768540834963
Battendieri8156854083417496120154193232247282304319
R,115068540834054
Siniscalco12206854083385391106132165198213245283
A1518685408346
et158068540833961
al.16576854083375265
Intraorbital17386854083205880101135173195235250273306322
injection20756854083205873108141165181219258
of234868540834362
Rituximab24266854083405679117148164222254294
in273568540832058
idiopathic2809685408320597442569540833777110132170185217
orbital6576954083365797112135168183
inflammatory855695408313516986118176233266288325346380
syndrome:12506954083255796135156194252287300
case15656954083296289124
reports.17046954083195392131153177205219
Rheumatol193869540833472107145203235257294310
Int.2263695408313517386
2015;35(1):23646954083336799129139174207225257271283
183-188.,26626954083336498120151182217230243
36.4257053085367288
Della‑Torre5287054083437994109141164194228249271305
E,84870540833144
Campochiaro90770540833871128167206239277292324345382
C,130570540833750
Cassione13707054083387197124139177215250
EB163570540833166
et171670540833254
al.17867054083294457
Intrathecal1859705408312507193126148186221253286302
rituximab2176705408318345694125141199231270
for24617054083165476
IgG4-related25527054083125196132155177211227259280314354
hypertrophic42571540833767105140160184205241280317332363
pachymeningitis.8027154083366899136165223257294308345383397419434459472
J1289715408321
Neurol132471540834276112133169184
Neurosurg152371540834175112132168194230251288
Psychiatry2018;18267154083315788119156170201222243276307340370401412
89:22537154083316476
441-444.23447154083316796114150186222234
doi:10.1136/2592715408335728799127158170200227256289313
jnnp-2017-3165194257254083155391130153184218250280298331362393426457488
pmid:2881906092872540833997112151163198232267299329365401436
37.4257353085367079
Mageau51973540835285124159190228
A,76273540833953
Shor83073540833068106128
N,97373540834355
Fisselier1044735408330457197132148163197218
M,127873540835265
et135973540833153
al.14287354083294457
Rituximab15017354083334871108140155213245284
for18017354083165375
corticosteroid‑resistant18917354083296687112127159196223246279300338353392414436470496511537560593631653
relapsing25597354083185268100139166180218257
IgG4-related28327354083125142574540834479102124158174206227261301
intracranial741745408312507193126158179212250265296312
pachymeningitis:106874540833669101139170228263301316354393408430445471484
report15677454083185291130152176
of175974540833454
two182874540831972110
cases.19537454083296188123150163
Pract21317454083335487119143
Neurol.228974540834277115136173189202
2018;18(2):159161.250674540833266971281401702012202542722843143433764257554083346596105
doi:5457554083387792104
10.1136/practneurol-2017-001826.6647554083356679109137167201227264286319351375413448486507544560583613648679709727764801832863897931944
38.3047553085367288
Gu31505540834583
WJ,3249554083587991
Zhang33565540833976109147186
Q,35575540834862
Zhu36345540833977114
J,37645540832537
et.3816554083355771
al.3902554083334861
Rituximab3979554083365174112143159216249288
was42825540835285111
used4409554083386499139
to45635540832360
treat4638554083234478110132
recurrent4785554083225689126147169203241263
IgG4-related50635540831655100136159181215230263284318358
hypophysitis5436554083396930476540833977117156186213228251266292
with3354654083536891129
ophthalmopathy34986540834079118139177210225283321361394415454484
as39976540833461
the4073654083246297
initial418565408317557092107139155
presentation:4355654083416296123158196218251272288326364376
A474765408343
case4805654083336692127
report4948654083225696135156181
and51446540833472111
literature527065408317325488109142164202223257
review.3047754083215587103137189199
Medicine32627540835489129144176191229264
(Baltimore)3541754083195588103125141198237258292310
2017:38667540833468100130140
96(244021754083347088122154
:e6934.)4191754083124682116149184197215
39.3047853085367184
Bullock3146854083337186101138171201
DR,3362854083427892
Miller346985408352678297132153
BS,3637854083326477
Clark3729854083375284105135
HB,3879854083427790
Hobday39848540834280119158190221
PM.4220854083328699
Rituximab4334854083334871108139155212244283
treatment4632854083194074106127185220257279
for4926854083165374
isolated501585408312387692124145179218
IgG4-related52488540831251961311541762092252573047954083225594
hypophysitis31579540833565105144183221252279293316331357
in35299540831250
a359495408329
teenage3638954083205388126158197232
female.38859540831650108140155190202
Endocrinol41029540833068107145177198214252290306
Diabetes4423954083425890129164186220246
Metab46859540835286109141180
Case4880954083387097132
Rep.50279540833368107119
2018;2018:180135.516195408332669712814017520924027128431334430471054083346696129141
doi:32031054083387692104
10.1530/EDM-18-0135.33221054083346678109139172207231265310366388419450473510542572605617
Epub395410540833371110149
2018411810540833468100131
Dec426510540834580113
28.43931054083346882
40.30471153085367388
Boharoon315011540833371109141162199237275
H,344011540834154
Tomlinson350911540833064121137151189215253291
J,381511540832133
Limback‑Stanic386311540832944101140172204234254285306338376390422
C4300115408337
et435211540833254
al.44211154083294457
A4493115408338
Case45461154083377096130
Series46921154083296485100135161
of486811540833554
Patients49371154083326485100135172193221
with51731154083486385123
Isolated5311115408312387691123145178217
IgG4-related30471254083155397133155177210226257279312351
Hypophysitis341312540834172112150189227257284298320335361
Treated37891254083304780111133166205
with40091254083486385123
Rituximab.41461254083334870108138154211242281293
J4454125408322
Endocr449112540833067105143175196
Soc.470212540833067100113
202048301254083316497130
Apr49751254083387798
21;4(6):bvaa048.50881254083326371105124157174186224256288320355391426439
doi:30471354083387692104
10.1210/jendso/bvaa048.31661354083346678109139170202226243277315354381419444484516549581617653689702
41.30471453085366982
Mammen314414540836194152211246285
SV,34441454083387685
Gordon354514540834988110149187226
MB.378714540836097110
Succesful391314540833876108140174201221260276
use420514540834269105
of432514540834363
rituximab44031454083264265103135151209242282
in470114540832058
case47751454083367096132
of492314540834262
Riedel50011454083415692132167183
thyreoiditis51991454083286697120154193209248264287302329
A3047155408341
resistant3103155408323578499125148181219240
to335915540832360
treatment34351554083234579111132190225264285
with37351554083536991129
prednisone38791554083416397136174189216254292327
and422215540833371110
tamoxifem.434815540832356114152183198217252310323
AACE468615540834386126158
Clin48601554083425772110
Case498515540834275101136
Rep.513715540833772111124
2019527615540833670102132
Apr542315540834383104
25;5(3):e218-e221.30471654083346980115133166183195230264296327349386420455486496
doi:35581654083387692104
10.4158/ACCR-2018-0352.36771654083346678113143173207232270309347383404435469501532555592625658691704
42.30471753085367086
Jalilian3148175408326587388103118150188
C,335217540834154
Prince34211754083365773111143176
HM,3613175408345100113
McCormack374217540835588129166188246278311341
C4098175408341
et415417540833558
al.42271754083334861
IgG4-related430417540831655100135158180214230262284318357
disease46771754083395480115147174209
with49011754083526790128
cutaneous50441754083337093126164199237276302
manifestations53611754083599112914430471854083185380103136157173211249276
treated33381854083274882114136170209
with35621854083567294132
rituximab:37101854083254163101133148206238278290
case40151854083376996131
report41611854083266099138160184
and436118540833775114
literature4490185408320355791112145167205226260
review.47661854083256092108142194204
Australas498618540834683109132154187202234261
J5262185408329
Dermatol.5307185408350851071651983047195408322597487
2014;55315019540833468100131143178210
(2):132-136.3376195408318527082112142174194225255290303
43.30472053085367186
Pomponio314820540833471129168207245260298
G,346220540834255
Olivari35322054083466277109142163179
D,372620540834455
Mattioli379620540835386107132147185201216
M4027205408353
et409520540833255
al.41652054083304658
Sustained42392054083316894117150165203238278
clinical4532205408330456098113145178193
response47402054083195380119158196223258
after50132054083304974108129
single51582054083243977116131166
course533920540833067105126153188
of304721540833757
rituximab3119215408322386098129145203235274
as340921540833360
first‑line3484215408318355684107127143158196231
monotherapy373021540835997136174196234269290323362394
in413921540831654
adult‑onset420921540833372110125147167207245271306329
asthma45532154083336083121179211
and478021540833371110
periocular49062154083407597112150183221236268289
xanthogranulomas52112154083316410212416220024026129430472254083387590129187219246
syndrome33082254083275998137158196254289
associated36122254083335986124157172204226259299
with39262254083516789128
IgG4-related40692254083155499135158180214230262284317357
disease:44412254083395480115147174209221
A4677225408342
case47342254083326592127
report.48762254083215594133155180193
Medicine508422540835590130145177192230265
(Baltimore).53642254083205588104126141304723540835796117151169180
2018;97(26):e11143.324223540833468100131143179212228262295314325360390417445476509521
doi:37782354083397792104
10.1097/MD.000000000001114338982354083346578109140175208228283329340375411447483520556592628664700736768796823854887
44.30472453085367490
Mochizuki315224540835795128166181210248279295
H,346224540834759
Kato35372454083377092129
M,368124540835770
Higuchi376724540834661100138170208223
T4005245408335
et405524540833659
al.41292454083344962
Overlap420724540834982116138153186225
of444724540834059
IgG4-related452124540831756101137160182216232264285319359
Disease48952454083486389124156183218
and512824540833472111
Multicentric5254245408357951101321481802132513047255408322435991
Castleman’s31532554083407399122138173231263301313338
Disease35062554083466187122154181216
in373725540831553
a3805255408332
Patient38522554083356789104139177198
with40662554083506688127
Skin42082554083326279117
Lesions.43402554083316592107145184210223
Intern45792554083155374108129168
Med476225540835590129
2017;56490625540833569100130140175209
(9):1095-1099.5130255408319516981111143178212234265296331367378
45.30472653085367186
McMahon314826540835789144177215253292
BA,34552654083377892
Novick356326540834685117132164194
T,377326540833443
Scheel383126540833567105140176191
PJ403826540833756
et410926540833658
al.41832654083344962
Rituximab42602654083375375113145160218250289
for45652654083205879
the46602654083236196
Treatment47722654083345186117139197232270292
of507926540834059
IgG4-Related515326540831756101137160197232247280301335375
Tubulointerstitial304727540833366106145160199214252274308330357381396419434467482
Nephritis:354527540835085125164185201223239265278
Case383827540834679106141
Report399527540834076115154176201
and421227540833775115
Review434227540834176109125160211
of456927540834262
the464627540832766101
Literature.47632754083365275109130163185224245279292
Medicine507027540836096136151183198237272
(Baltimore)53582754083235993108131146304728540835796117151169
2015;94323128540833468100130141176212
(32)34582854083195385103
e1366.35762854083346494129164177
46.30472953085367489
Quattrocchio315229540834886118140164186223256287325340378
G,354529540834458
Barreca36182954083366990112146178211
A,384529540834155
Demarchi391629540834581139171192223261276
A4208295408341
et426429540833557
al.43362954083334861
IgG4-related44122954083155599135158180214230262284318357
kidney47842954083314786124159190
disease:49902954083385379114146173208220
the52262954083226095
effects53362954083355473108140165192
of304730540833757
a3119305408334
Rituximab‑based31683054083375375113145160218250289313353386412447487
immunosuppressive367030540831775132170208246273310349389411445472498513545580
therapy.42653054083246297118151190222232
Oncotarget.451230540834988120157179211233271306328341
2018;9(30):21337–21347.486830540833771103134146181200234269287299334365395428460493524556586621653659
doi:30473154083387692104
10.18632/oncotarget.25095.31663154083346678109140175209242268303342374411433465487525560582595631666700735769781
47.30473253085367079
Eroglu31413254083375895135150188
E,334432540833750
Sipahioglu34093254083365190123161176214254269307
MH,3731325408359103116
Senel386332540833671109144160
S4038325408337
et409032540833860
al.41663254083365164
Successful424532540833774106137171198224244283298
treatment45583254083264882114135193228267288
of486132540834261
tubulointerstitial493732540832664103141157195210248270303325352375390413428460475
nephritis54283254083417630473354083397798114136152178
in324033540831553
immunoglobulin330833540831572130168206244284299337377415430445483
G4-related380633540834480103125159175207229262302
disease41233354083385480115147173208
with43463354083516789127
rituximab:4489335408320365896128143201233272285
A4789335408341
case48453354083326591126
report.49863354083215594133155180193
World519433540835894116132170
J5380335408324
Clin54193354083405570108
Cases.30473454083407399134161175
2019;7(16):2309-2315.323734540833468100130143176192224255273285320355390425448479514545575587
doi:38393454083387792104
48.30473553085367490
Lanzillotta315235540833366104134149164179218239264297
M,346435540835569
Della‑Torre35483554083478298113145167197231253275309
E,387235540833447
Wallace393435540835990105120153185219
ZS416835540833973
et425635540833557
al.43293554083324861
Efficacy4405355408334516987119152184218
and463835540833371110
safety47633554083276180114136170
of494835540833958
rituximab5021355408322386098129145203235274
for53103554083205779
IgG4-related54043554083165510030473654083345678111127158180213252
pancreato‑biliary331436540833668105137158191223244280303343358373387419439473
disease:38023654083355076110141167202214
A4031365408338
systematic40843654083235582105138195227248263294
review4393365408318528499133184
and459136540832967105
meta‑analysis.471136540835589111143165197234266281312339353379392
Pancreatology.511836540833264101133154187218240276292329368400409
2021304737540833468100132
Oct;21(7):1395-1401.319437540834477101114148180194229248260289319352386408438469505537546
doi:10.1016/j.pan.2021.37553754083357389101130161174204236267298323339352391424462475511545577608618
06.43883754083316780
009.448337540833268103114
Epub461237540833068106145
202147723754083326698130
Jul49173754083225974
3.500637540833244
PMID:506637540833286101146159
34244040.524037540833267100131168204240275288
49.30473853085367285
Gillispie3147385408349658095110136175191226
MC,3388385408360100113
Thomas351738540833877115174206233
RD,37653854083418798
Hennon387838540835085123161199238
TR.41313854083387590
Successful423638540833875107138172199226246284300
treatment45513854083274883114136195230268289
of485638540834262
IgG-4493338540832059104127164
related51123854083266076108130164204
sclerosing5331385408331647911413517230473954083264179118
disease31803954083385379114146173208
with34033954083506688127
rituximab:3545395408320365896128143201233273285
a3845395408332
novel389239540833776108142158
case40653954083316490125
report.42063954083205493132154178192
Clin44133954083405570108
Exp453639540833365105
Rheumatol465639540833573108146204236258295311
2015;33498239540833468100130141176209
(4):549-550.5206395408319526981116151184208242274309321
50.30474053085367287
Nikolic31494054083496494132148162194
S,335940540833649
Panic342340540833971109124156
N,359540540834861
Hintikka367240540834863101122138168199232
ES392040540833670
et400640540833760
al.40814054083365164
Efficacy4161405408336547290122155187220
and439740540833573112
safety45254054083306382116139172
of471340540834160
rituximab47894054083244062100132147205237276
in508140540831856
autoimmune51534054083357395132148206263301339374
pancreatitis304741540833972110142163197229251266288304330
type33924154083225595131
1:353841540833443
our35964154083377596
experiences370841540833365104140161177212250282315342
and406641540833169108
systematic41904154083265885108142200232254269301
review45074154083205486102137188
of471041540833757
the47824154083216095
literature.4892415408315295286107140162200221255267
Scand51744154083336598136175
J5364415408324
Gastroenterol.54034154083447710330474254083224380116154176209230268284297
2021;56(11):1355-1362.335942540833468101132141176210229261288303315345374407440462493523557591603
doi:39774254083387792104
10.1080/00365521.2021.1963837.40974254083346578108140175211235269305338373406439472504513549583616647657687718753787821855887893
Epub500642540833271110149
2021517042540833468101133
Aug531842540834178117
19.54504254083346576
51.30474353085356880
Terumi31424354083295980117173188
Kamisawa,334443540833265121136161193243274287
Takahiro36454354083305786119156170190227
Nakazawa,388643540834273102135164196245277290
Susumu41904354083306691128184221
Tazuma,44254354083305785123179210223
et466243540833153
al.47294354083294456
Clinical47994354083375266103117148180195
practice50084354083365789120143158189222
guidelines52444354083357286124158173187224258284
for30474454083185678
IgG4-related31404454083135397133156178212228260282316355
sclerosing35104454083255873108129166193208246285
cholangitis.381044540833068106122154192231247269284310324
J4149445408323
Hepatobiliary418844540834378117150172209248264279294326347381
Pancreat458444540833466104136158192224245
Sci.4845445408331637891
201949524454083336798129
Jan;50964454083235593105
26(1):52164454083336786117132144
9–42.537544540833371107140153
52.30474553085367187
Peisen31494554083356884110145183
F,334745540833238
Thaiss340045540833272104119145172
WM,3587455408357112125
Ekert37284554083326296117142
K3885455408334
et393545540833355
al.40064554083314759
Retroperitoneal40814554083357092113151190226247263285322360395427443
Fibrosis45394554083324786108145172186212
and476745540833169108
its48914554083143664
Differential4970455408345618099134155189227249264296311
Diagnoses:529745540834460921311692073047465408326608799
The316146540833069103
Role32794654083337186121
of341546540833453
Radiological348346540833365104118156172209248263295327342
Imaging.384046540831269101140155192231244
Rofo.40994654083327089126138
2020;192(10):929-936.42524654083326598131144174203236253284315334345380413446470504536570583
doi:48504654083367388100
10.1055/a-1181-9205.49654654083326375105136170202226256278308335366397416450483517550562
Epub304747540833372110149
2020321147540833468101135
Jul33624754083246277
22.34544754083356982
PMID:32698236.355147540833589104150163199231265299334367402436450
53.30474853085367186
Kawano314848540833670121153191230
M,339348540835569
Saeki347748540833467101132148
T,364148540833342
Nakashima369848540834678108142169206221279311
H.402548540834558
IgG4-related40994854083155499135158180214230262284317357
kidney44714854083314786124159191
disease46774854083395480115147174209
and490148540833371110
retroperitoneal50264854083225678100137176212233249271308347382414429
fibrosis:54704854083183530474954083396097124139165178
An324049540834482
update.333749540834180119152173207219
Mod357249540835795135
Rheumatol.372249540833977112150208240262299315328
2019;29(2):231-239.406549540833771103133146181215234268286298333368399417448483516527
doi:10.1080/14397595.2018.1554346084954083417994107136168180211243278313338371402435468501533566600612648682714745758789819852887919
21.30475054083346675
Epub313750540833372110149
2019330250540833468100130
Jan34475054083245694
8.355750540833447
54.30475153085367388
Forestier31505154083326991125152175190225246
A,341151540834054
Buob348151540833472110150
D,364651540834555
Mirault37175154083536990123160176198
T3931515408331
et397751540833456
al.40485154083314659
No412351540834382
specific422051540832564100132148165182214
imaging445051540831371103142158196235
pattern47005154083387192117150172210
can492651540833063101
help50425154083377287126
differentiate5184515408337527291125146180218240255287309343
IgG4-related30475254083155499134157179214229261283317356
disease34195254083365278113145171206
from36405254083174077135
idiopathic37905254083145368106145178200238253285
retroperitoneal4091525408319537597134174209230246268305344379411426
fibrosis:4532525408316337293131157172198211
18475852540833364
histologically48375254083375278101138154192231247279311327342374
proven52265254083375996128162200
cases.54425254083306330475354083266188102
Clin31645354083405570108
Exp328753540833365105
Rheumatol.340753540833574109147204237259295311324
2018;36(3):371-375.374753540833468100131143178212231265282294329361394412445477510522
55.30475453085367185
Raglianti314754540834072111127142174212233248
V,341154540833948
Rossi347554540833977104130145
GM,3636545408347102115
Vaglio376754540833971110125140178
A.396054540834560
Idiopathic40355454083195873111150183205243258290
retroperitoneal43415454083245881102139179215236251274311349384416431
fibrosis:4788545408321387798135162177203216
an501954540833674
update510854540834180120152174208
for53315454083226081
nephrologists.54285454083417630475554083397798136151190229244270294321335
Nephrol339755540834580119158179216232
Dial36445554083466193108
Transplant.37685554083325083121147186202234272293307
2021;36(10):1773-1781.doi:409055540833468101133141176210229261292311323353382417451473503533566598607646685700712
10.1093/ndt/gfaa083.48185554083346578108140175208232269308330358393413446479514550584596
56.30475653085377491
Wallwork315556540836497113129181220243275
R,344656540834256
Wallace351856540836597113129163196231
Z,376556540834458
Perugino38395654083417698138178194234273
C4128565408347
et419156540834063
al.42705654083385568
Rituximab43545654083425882121153170229263303
for46745654083246385
idiopathic47755654083216177116157192214254270303
and509456540833877118
IgG4-related52285654083206110714416819122724327630475754083225899
retroperitoneal31635754083316790113152194231254271295334374411445461
fibrosis.36415754083274485108147176192219234
Medicine3892575408365102144160194210250287
(Baltimore).419557540832967102118142159219259282318337349
2018;97(42):e12631.456057540834581114147161198233250285319339352388419451486522554565
doi:514257540834888105118
10.1097/52775754083457892124157194229250
MD.0000000000012631.3047585408354100112147183219255291327363400436472508540570603637668677
57.30475953085367180
Boyeva314259540834179110145177210
V,336759540834150
Alabsi34325954083466294133160175
H,362259540834962
Seidman36995954083387388127185217255
MA3970595408359101
et408659540833962
al.41635954083375265
Use424359540834975110
of436859540834362
rituximab44455954083264264102133149207239278
in473959540831957
idiopathic48115954083205974112152185206245260292
retroperitoneal51185954083266082104141180216237253275312351386304760540833247
fibrosis.3109605408317347395132159174200213
BMC333860540833590131
Rheumatol.348460540833574109147204237258295311324
2020;4:40.382460540833468101135148182194229265277
doi:41176054083387691104
10.1186/s41927-020-00140-9.42366054083346578109136168203228252288319349382415433471504538561599635667698734757792803
PMID:505560540833588104150163
32775962;523360540833467100134167199235268281
58.30476153085367288
Almeqdadi315061540834358116151190230262301316
M,348161540835770
Al‑Dulaimi35666154083435880128166181213229286301
M,388361540835669
Perepletchikov39686154083367091125164180215237268306321351389421
A,440461540834257
et447661540833558
al.45496154083334962
Rituximab46266154083375375113144160217250289
for49306154083205880
retroperitoneal50256154083225679100137177212234249272309347382414429
fibrosis54706154083183530476254083396097124139165
due322762540833875110
to335262540832158
IgG4-related34256254083145398134157179213228261282316356
disease:37966254083375278113145172207219
A4031625408340
case40866254083306390125
report42266254083205493132153178
and441962540833169108
literature4542625408314295285107140161199221255
review.48126254083205486102136188198
Clin50266254083395469107
Nephrol514862540834479118156178215231
Case53946254083397298133
Stud.30476354083325492131144
2018320663540833468100131
Apr335263540834181102
27;6:4-10.34706354083346776112125159182213244257
doi37426354083387692
10.5414/CNCS10932138496354083346678114149179210235274319360394425456491524557588
59.30476453085367184
Hamdan314664540834779137176208246
A,340864540834357
Moeen348064540835795131166204
Z,370064540833953
Tariq3768645408335638499138
H3921645408347
et398364540833658
al.40576454083344962
An413464540834382
Interesting42316454083175576110131165192215231269308
Case455464540834275101136
of470664540833958
Immunoglobulin478064540831775132170208246286301339379417432447485
G4-Related52816454083458110414117619222430476554083225696
Retroperitoneal31586554083417699121158198234256271294331370406438453
Fibrosis36276554083385392114152179194220
Treated38636554083375589121143178217
With409665540836379102141
Rituximab.42526554083415779118149165223256295308
Cureus.457665540834582103138176202216
2021480865540833973107138
Sep496265540833873113
13;13(9):e17940.50906554083407082112142161194212224259289318352388424437
doi:10.7759/cureus.17940.30476654083387692104134165178212246279311335363401422456494520534565594628663699712
60.30476753085367388
Rossi315167540834179106132147
GM,3314675408348103117
Rocco344667540834079111142179
R,364067540834155
Accorsi371067540834678109145167194209
Buttini393467540834179101126141179194
E4143675408338
et419667540833962
al.42736754083375265
Idiopathic43536754083205974112152185207245260292
retroperitoneal46606754083266083104141181216238253276313351386418433
fibrosis5109675408322397899137163178204
and532967540833674113
its54586754083194270
overlap304768540833769103125141173212
with32746854083516689127
IgG4-related34166854083155499135158180214229262283317357
disease.37886854083385379114146173208220
A.402368540834156
Intern40946854083155375108130168
Emerg427768540833391126147185
Med.447768540835590129143
2017;12:287–299.463568540833468100129139169199212247281314346378412447458
61.30476953085377083
Kermani31476954083407698157191230245
TA,34086954083397791
Crowson351569540834668106159186226265
CS,37966954083468194
Achenbach390669540834779118154193233267300339
SJ.42616954083396477
Idiopathic43546954083206076115156190212251267300
retroperitoneal46706954083266184106144185221243259283321360396429445
fibrosis:51316954083223979102140167183210223
a5370695408337
retrospective5423695408327628530477054083215986126163196221236270305
review33687054083266194110145198
of358170540834363
clinical36607054083375368107123155189205
presentation,388170540834466101129164203225259281297336375388
treatment,42857054083274984117139198234273295309
and461070540833776116
outcomes.474270540834382105136174233269297311
Mayo506970540836093125163
Clin52487054083466277116
Proc.538070540834162100133147
2011;86:297–303.304771540833468100128136171207219254288321354386420454466
62.30477253085367187
Marcolongo314972540835386107138175191229267306345
R,350972540833448
Tavolini35727254083315991128144159197212
IM,37997254083136882
Laveder38967254083306495129169204225
F4136725408331
et418272540833355
al.42537254083304558
Immunosuppressive432672540831471129167205243270307346386407441468495510542577
therapy49187254083205893114147187218
for51517254083175576
idiopathic52437254083135167105144177199237252284
retroperitoneal3047735408321557798136175211232248270307346381412428
fibrosis:3490735408317347395132159173199212
a3717735408332
retrospective3764735408321557799136163202237270294309342376
analysis415673540833169102117149176191217
of438873540833757
26446073540833468
cases.45437354083316491126152166
Am472473540834199
J4839735408324
Med.487873540835590129142
2004;116:194–197503673540833468104140152182210241254283314349387418448481
63.30477453085367287
Scheel314974540833264102137172188
PJ,33527454083345466
Feeley343374540833165100116151182
N,363174540834356
Sozio37027454083327098114152
SM386974540833186
Combined397074540833976134173189227262301
prednisone42877454083375993132170185212250288323
and462674540833068107
mycophenolate474974540835686118155194233268306344360392414448
mofetil521274540835695114148171186201
treatment54297454083204276304775540833254112147185206
for32697554083185677
retroperitoneal3362755408320547798135175210232247270307345380412427
fibrosis:3805755408317347394131158173199212
a4032755408332
case40797554083316491126
series.4220755408326618298133159173
Ann440875540834179117
Intern45417554083155274108129168
Med.472475540835489129142
2011;154:31–36.488275540833468100127135166196231243278309342374409422
64.30477653085367489
Marzano315276540835789110141175213251
A,341876540834357
Trapani34917654083345184124157195210
A,371676540834357
Leone378876540833468107145180
N3983765408347
et404576540833659
al.41197654083344962
Treatment41977654083345185117139197232270292
of450476540833959
idiopathic45787654083175671109148181203241256288
retroperitoneal48827654083225679100137177212234249272309347382414429
fibrosis5327765408319367596133160175201
using30477754083376378116155
cyclosporin.32187754083316496111149176215254275291329342
Ann357577540834179117
Rheum,370877540833573108146204217
DiS.39407754083456193107
2001;60:427–428.406277540833468104136144180216229263296329361398430464478